Early life stress and tumor necrosis factor superfamily in crack cocaine withdrawal

Journal of Psychiatric Research

Volumn 53, Issue 1, 2014, Pages 180-186

  Levandowski, Mateus Luz ^a   Viola, Thiago Wendt ^a   Wearick Silva, Luis Eduardo ^a   Wieck, Andréa ^a   Tractenberg, Saulo Gantes ^a   Brietzke, Elisa ^b   Bauer, Moisés E ^a   Teixeira, AntÔnio Lúcio ^c   Grassi Oliveira, Rodrigo ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Child abuse; Cytokines; Inflammation; Substance related disorders; TNF; TRAIL; TWEAK

Indexed keywords

COCAINE; LIGAND; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; CYTOKINE; TNFSF12 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ABSTINENCE SEVERITY; ADULT; APOPTOSIS; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; CHILD ABUSE; CHILD NEGLECT; CHILDHOOD MALTREATMENT SEVERITY; CHILDHOOD TRAUMA QUESTIONNAIRE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DEPRESSION SEVERITY; DISEASE SEVERITY; DOWN REGULATION; EARLY LIFE STRESS; ENZYME LINKED IMMUNOSORBENT ASSAY; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; FLOW CYTOMETRY; HUMAN; MOOD DISORDER; MULTIPLE LINEAR REGRESSION ANALYSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME; BLOOD; COMPLICATION; ETIOLOGY; MALE; MENTAL STRESS; NONPARAMETRIC TEST; PHYSIOLOGY; PSYCHOLOGY; QUESTIONNAIRE; SIGNAL TRANSDUCTION; STATISTICS; YOUNG ADULT;

ADULT; CRACK COCAINE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; QUESTIONNAIRES; SIGNAL TRANSDUCTION; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; STRESS, PSYCHOLOGICAL; SUBSTANCE WITHDRAWAL SYNDROME; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS; YOUNG ADULT;

EID: 84897406754     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.02.017     Document Type: Article

References (43)

1. Bernstein D.P., Stein J.A., Newcomb M.D., Walker E., Pogge D., Ahluvalia T., et al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl 2003, 27:169-190.
2. Brenhouse H.C., Andersen S.L. Nonsteroidal anti-inflammatory treatment preventsdelayed effects of early life stress in rats. Biol Psychiatry 2011, 70:434-440.
3. Brietzke E., Kapczinski F. TNF-alpha as a molecular target in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1355-1361.
4. Burkly L.C., Michaelson J.S., Hahm K., Jakubowski A., Zheng T.S. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. Cytokine 2007, 40:1-16.
5. Carpentier I., Coornaert B., Beyaert R. Function and regulation of tumor necrosis factor receptor type 2. Curr Med Chem 2004, 11:2205-2212.
6. Chen G., Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 2002, 296:1634-1635.
7. Chorianopoulos E., Rosenberg M., Zugck C., Wolf J., Katus H.A., Frey N. Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure. Eur J Heart Fail 2009, 11:1050-1056.
8. Coelho R., Viola T.W., Walss-Bass C., Brietzke E., Grassi-Oliveira R. Childhood maltreatment and inflammatory markers: a systematic review. Acta Psychiatr Scand 2014, 129:180-192.
9. Danese A., Pariante C.M., Caspi A., Taylor A., Poulton R. Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci USA 2007, 104:1319-1324.
10. Del-Ben C.M., Vilela J.A., Crippa J.A., Hallak J.E.C., Labati C.M., Zuardi A.W. Reliability of the structured clinical interview for DSM-IV - clinical version translated into Portuguese. Braz J Psychiatry 2001, 23:156-159.
11. Dennison U., McKernan D., Cryan J., Dinan T. Schizophrenia patients with a history of childhood trauma have a pro-inflammatory phenotype. Psychol Med 2012, 42:1865-1871.
12. Falschlehner C., Schaefer U., Walczak H. Following TRAIL's path in the immune system. Immunology 2009, 127:145-154.
13. Fox H.C., D'Sa C., Kimmerling A., Siedlarz K.M., Tuit K.L., Stowe R., et al. Immune system inflammation in cocaine dependent individuals: implications for medications development. Hum Psychopharmacol 2012, 27:156-166.
14. Goetz F.W., Planas J.V., MacKenzie S. Tumor necrosis factors. Dev Comp Immunol 2004, 28:487-497.
15. Gomes-Oliveira M.H., Gorenstein C., Lotufo Neto F., Andrade L.H., Wang Y.P. Validation of the Brazilian Portuguese version of the Beck Depression Inventory-II in a community sample. Rev Bras Psiquiatr 2012, 34:389-394.
16. Granell S., Pereda J., Gomez-Cambronero L., Cassinello N., Sabater L., Closa D., et al. Circulating TNF-alpha and its soluble receptors during experimental acute pancreatitis. Cytokine 2004, 25:187-191.
17. Grassi-Oliveira R., Brietzke E., Pezzi J.C., Lopes R.P., Teixeira A.L., Bauer M.E. Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder. Psychiatry Clin Neurosci 2009, 63:202-208.
18. Grassi-Oliveira R., Cogo-Moreira H., Salum G.A., Brietzke E., Viola T.W., Manfro G.G., et al. Childhood Trauma Questionnaire (CTQ) in Brazilian samples of different age groups: findings from confirmatory factor analysis. PLoS ONE 2014, 9:e87118.
19. Grassi-Oliveira R., Stein L.M., Pezzi J.C. Translation and content validation of the Childhood Trauma Questionnaire into Portuguese language. Rev Saude Publica 2006, 40:249-255.
20. Haroon E., Raison C.L., Miller A.H. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012, 37:137-162.
21. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991, 86:1119-1127.
22. Kampman K.M., Volpicelli J.R., McGinnis D.E., Alterman A.I., Weinrieb R.M., D'Angelo L., et al. Reliability and validity of the cocaine selective severity assessment. Addict Behav 1998, 23:449-461.
23. Kendler K.S., Myers J., Prescott C.A. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. Arch Gen Psychiatry 2007, 64:1313-1320.
24. Kessler F., Cacciola J., Alterman A., Faller S., Souza-Formigoni M.L., Cruz M.S., et al. Psychometric properties of the sixth version of the Addiction Severity Index (ASI-6) in Brazil. Rev Bras Psiquiatr 2012, 34:24-33.
25. Kiecolt-Glaser J.K., Gouin J.P., Weng N.P., Malarkey W.B., Beversdorf D.Q., Glaser R. Childhood adversity heightens the impact of later-life caregiving stress on telomere length and inflammation. Psychosom Med 2011, 73:16-22.
26. Kralisch S., Ziegelmeier M., Bachmann A., Seeger J., Lossner U., Bluher M., et al. Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease. Atherosclerosis 2008, 199:440-444.
27. Levandowski M.L., Viola T.W., Tractenberg S.G., Teixeira A.L., Brietzke E., Bauer M.E., et al. Adipokines during early abstinence of crack cocaine in dependent women reporting childhood maltreatment. Psychiatry Res 2013, 210:536-540.
28. Maecker H., Varfolomeev E., Kischkel F., Lawrence D., LeBlanc H., Lee W., et al. TWEAK attenuates the transition from innate to adaptive immunity. Cell 2005, 123:931-944.
29. de Meneses-Gaya C., Zuardi A.W., de Azevedo Marques J.M., Souza R.M., Loureiro S.R., Crippa J.A. Psychometric qualities of the Brazilian versions of the Fagerstrom Test for Nicotine Dependence and the Heaviness of Smoking Index. Nicotine Tob Res 2009, 11:1160-1165.
30. Miller A.H., Haroon E., Raison C.L., Felger J.C. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety 2013, 30:297-306.
31. Nakajima A., Yamada K., Nagai T., Uchiyama T., Miyamoto Y., Mamiya T., et al. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity. JNeurosci 2004, 24:2212-2225.
32. Niwa M., Nitta A., Yamada K., Nabeshima T. The roles of glial cell line-derived neurotrophic factor, tumor necrosis factor-alpha, and an inducer of these factors in drug dependence. JPharmacol Sci 2007, 104:116-121.
33. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006, 27:24-31.
34. Saas P., Boucraut J., Walker P.R., Quiquerez A.L., Billot M., Desplat-Jego S., et al. TWEAK stimulation of astrocytes and the proinflammatory consequences. Glia 2000, 32:102-107.
35. Shin S.H., Miller D.P., Teicher M.H. Exposure to childhood neglect and physical abuse and developmental trajectories of heavy episodic drinking from early adolescence into young adulthood. Drug Alcohol Depend 2013, 127:31-38.
36. Steptoe A., Ussher M. Smoking, cortisol and nicotine. Int J Psychophysiol 2006, 59:228-235.
37. Tansey M.G., Szymkowski D.E. The TNF superfamily in 2009: new pathways, new indications, and new drugs. Drug Discov Today 2009, 14:1082-1088.
38. Van Zee K.J., Kohno T., Fischer E., Rock C.S., Moldawer L.L., Lowry S.F. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha invitro and invivo. Proc Natl Acad Sci USA 1992, 89:4845-4849.
39. Wajant H. TRAIL and NFkappaB signaling-a complex relationship. Vitam Horm 2004, 67:101-132.
40. Wang S., El-Deiry W.S. TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 2003, 22:8628-8633.
41. Wieck A., Andersen S.L., Brenhouse H.C. Evidence for a neuroinflammatory mechanism in delayed effects of early life adversity in rats: relationship to cortical NMDA receptor expression. Brain Behav Immun 2013, 28:218-226.
42. Wiley S.R., Winkles J.A. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Cytokine Growth Factor Rev 2003, 14:241-249.
43. Willett W.C., Howe G.R., Kushi L.H. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997, 65:1220S-1228S. [discussion 1229S-1231S].